|Yleinen keskustelu: 86 aihetta|
1 2 3 4 5 6 7 8 9 Näytä kaikki listana
Älä Tyly välitä Kukuskan pilkkapuheista. Meidän perunamaalla on tilaa sinunkin viljeltäväksi. DCA:sta vielä
16.09.2008 - 02:13 | Virtanen, Espoo
For the first time in the world, on December 7, 2007 we publicly shared our observational data from the treatment of 118 cancer patients with DCA. In March 2008 we updated our data from treating over 175 patients.
As of August 2008, we have treated over 265 cancer patients with DCA.
Results of the analysis of our latest data are very similar to our two earlier reports.
We continue to see responses to DCA treatment in a variety of cancers including but not limited to lung, brain, colon, breast, ovary and pancreas. While we cannot comment on the cancer- specific response rates with confidence due to the relatively low numbers, our overall positive response rate continues to be between 60 – 70%. A positive response can be in the form of tumour shrinkage, cancer marker reduction, blood test improvement, symptomatic improvement, disease stabilization or a combination of any of these. In 30 - 40% of our patients we have not seen a response to treatment which is similar to our previous experience. This group includes patients whose disease progresses in spite of DCA treatment as well as patients where we are uncertain of the response to DCA treatment. Note that our reported response rate is not directly comparable to published response rates for chemotherapy and other standard cancer treatments.
Due to the consistently similar results of our latest analyses to the previous updates in December 2007 and March 2008, we have decided to present some case reports of our therapies instead of a complete observational data update. If our data starts to show significant differences from our last update, we will post our new findings.
The case reports presented here are not necessarily chosen based on the best responses to treatment but are a mix of our earlier experiences, variation in responses and tumor types, and combination therapies.
The purpose of sharing these case reports on our website is to reach as wide an audience as possible with the hope that it may give support and encouragement to other cancer patients and health care providers everywhere. These case reports are for information only and should not be used as a guide to self medicate. We plan to update these with new cases regularly.
Nato-ovesta? - 10.09.2008 - 08:23